Search alternatives:
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side release » size released (Expand Search), live release (Expand Search), slow release (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant side » significant sex (Expand Search), significant burden (Expand Search), significant source (Expand Search)
side release » size released (Expand Search), live release (Expand Search), slow release (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3).
Published 2019“…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”
-
158
Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report
Published 2024“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
-
159
-
160
<i>Mycobacterium tuberculosis</i> thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity
Published 2020“…We also show that the intracellular [dTTP]/[dATP] ratio in <i>Mycobacterium smegmatis</i> (Msm) cells decrease upon treatment with plumbagin, and this, in turn, leads to cell death. …”